Axon Enterprise issues USD 1.15 billion notes and Axon Enterprise stock trades at EUR 369.50
π Axon Enterprise reported Q2 2026 revenue of USD 904.39 million, a 35.30 percent year-over-year increase driven by strong demand for its security technology solutions.
π° The company issued USD 1.15 billion in zero-coupon convertible notes due 2031 to strengthen its balance sheet and fund future growth initiatives.
π Annual recurring revenue grew 39 percent to USD 1.60 billion, while future contracted bookings increased 41 percent to USD 15.10 billion in the second quarter.
π Axon lifted its full-year 2026 revenue-growth guidance to a range of 32 percent to 34 percent, signaling confidence in sustaining high growth rates.
π Goldman Sachs maintained a Buy rating but cut its price target from USD 715.00 to USD 675.00, reflecting concerns about valuation relative to growth.
π¦ The convertible notes carry no regular interest and have an initial conversion price of USD 652.06 per share, with capped calls intended to reduce dilution.
π Adjusted EBITDA reached USD 242.00 million in Q2 2026, resulting in a healthy 26.80 percent margin on the expanded revenue base.
π GAAP net income for the quarter was USD 29.00 million, demonstrating profitability despite significant investments and debt issuance.
π Axon's stock traded at EUR 369.50 on October 5, 2026, up 0.56 percent versus the prior close, trading within its 52-week range of USD 339.01 to USD 764.02.
π₯ MarketBeat listed a consensus Moderate Buy view from analysts, with 14 Buy ratings and three Hold ratings as of October 1, 2026.
- Axon Enterprise achieved Q2 2026 revenue of USD 904.39 million, a robust 35.30 percent year-over-year increase that validates its market leadership in security technology.
- The company successfully issued USD 1.15 billion in convertible notes to secure capital for expansion while maintaining profitability with USD 29.00 million in GAAP net income.
- Annual recurring revenue surged 39 percent to USD 1.60 billion, indicating strong customer retention and recurring value from its core products.
- Future contracted bookings jumped 41 percent to USD 15.10 billion, demonstrating a robust pipeline of new sales and market share gains.
- Axon lifted its full-year 2026 revenue-growth outlook to 32-34 percent, showing management confidence in sustaining high growth despite elevated stock valuation.
- Goldman Sachs cut its price target from USD 715.00 to USD 675.00, suggesting that the current stock valuation may be stretched relative to expected earnings growth.
- The issuance of USD 1.15 billion in zero-coupon convertible notes adds a future equity-linked obligation and potential dilution risk if conversion occurs.
- Analyst consensus is Moderate Buy rather than Strong Buy, indicating that some investors remain cautious about the company's ability to sustain its rapid growth pace.